Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.97B
Revenue (ttm)	1.51B
Net Income (ttm)	100.93M
Shares Out	n/a
EPS (ttm)	1.22
PE Ratio	39.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	855,636
Average Volume	507,514
Open	51.00
Previous Close	50.51
Day's Range	47.19 - 51.00
52-Week Range	35.67 - 79.83
Beta	0.18
RSI	35.50
Earnings Date	Aug 8, 2025

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 193
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In 2024, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.